1. Hammer S, Katzenstein D, Hughes M, Gondacker H, Hirsch M, Merigan T, for the ACTG 175 study team. Nucleoside monotherapy vs combination therapy in HIV-infected adults: a randomized, double-blind, placebo-controlled trial in persons with CD4 cell counts 200–500/mm 3. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, September, 1995: abstr LB1.
2. Combination superior to zidovudine in DELTA trial;Choo;Lancet,1995
3. Cameron B, Heath-Chiozzi M, Kravcik S, et al. Prolongation of life and prevention of AIDS in advanced immunodeficiency with riton avir. 3 rd Conference on Retrovi ruses and Opportunistic Infections, Washington DC, February, 1998: abstr LB6a.
4. Gulick R, Mellor J, Havlir D, et al. Potent and sustained antiretroviral activity of indinavir in combination with zidovudine and lamivudine. 3rd Conference on Retrov i ruses and Opportunistic Infections. Washington DC, February, 1998: abstr LB7.